PRKDC and Ewing sarcoma: Independent of Wee1 inhibition, DNA-PK inhibitors when used in combination with topoisomerase 2 poisons, such as etoposide or doxorubicin, have demonstrated synergy in in vitro and in vivo models of ES [125].